Trials / Completed
CompletedNCT04868916
An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
Prospective Observational Study to Estimate the Genotype and Phenotype of Japanese Patients With X-linked Retinitis Pigmentosa Associated With Pathogenic Variants in Retinitis Pigmentosa GTPase Regulator (RPGR)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Janssen Pharmaceutical K.K. · Industry
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to identify a cohort of Japanese participants with X-linked retinitis pigmentosa (XLRP) associated with pathogenic variants in the retinitis pigmentosa GTPase regulator (RPGR) gene and to investigate their associated phenotype.
Conditions
Timeline
- Start date
- 2021-07-26
- Primary completion
- 2024-04-23
- Completion
- 2024-04-23
- First posted
- 2021-05-03
- Last updated
- 2025-04-25
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT04868916. Inclusion in this directory is not an endorsement.